Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Azim

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Cell|January 30, 2016
Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic ObesityKevin Dalgaard, Kathrin Landgraf, Steffen Heyne, et al.
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Science (New York, N.Y.)|March 10, 2021
SARS-CoV-2 within-host diversity and transmissionKatrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Cell|January 30, 2016
Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic ObesityKevin Dalgaard, Kathrin Landgraf, Steffen Heyne, et al.
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Science (New York, N.Y.)|March 10, 2021
SARS-CoV-2 within-host diversity and transmissionKatrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Pageof 27